Evidence map›Paper›PMID 22433836›Full record

ArticleJournal of vascular research2012

Related transcriptional enhancer factor 1 increases endothelial-dependent microvascular relaxation and proliferation.

Angela F Messmer-Blust, Cuili Zhang, Jue-Lon Shie, Qinhui Song, Ping He, Isabel Lubenec, Yuhong Liu, Frank Sellke, Jian Li

Open access · bronzeAbstract read
In one paragraph

Article in Journal of vascular research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. A novel intronic circular RNA circFGFR1Journal of translational medicine · 2023
    Article
  2. Article
  3. Endothelial-Dependent Vasomotor Dysfunction in Infants After Cardiopulmonary Bypass.Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies · 2020
    Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Angela F Messmer-BlustDivision of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA.
Cuili Zhang
Jue-Lon Shie
Qinhui Song
Ping He
Isabel Lubenec
Yuhong Liu
Frank Sellke
Jian Li
Beth Israel Deaconess Medical Center · USBrown University · USHarvard University · USRhode Island Hospital · US

Funding

Training Program in Cardiovascular ResearchT32HL007374 · NHLBI · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI MITTLEMAN, MURRAY A · 1985 to 2019
$7.9M
Surgical Intramyocardial Angiogenesis in a Swine Model of Endothelial DysfunctionR01HL069024 · NHLBI · RHODE ISLAND HOSPITAL · PI SELLKE, FRANK W · 2002 to 2011
$3.7M
The Role of RTEF-1 in Angiogenesis and Myocardial IschemiaR01HL082837 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI LI, JIAN · 2007 to 2011
$2.4M
NHLBI NIH HHS R01 HL069024NHLBI NIH HHS R01 HL082837NHLBI NIH HHS R01HL082837NHLBI NIH HHS R01HL69024NHLBI NIH HHS T32 HL007374NHLBI NIH HHS T32HL007374
6 · The paper itself

Abstract

objectiveRelated transcriptional enhancer factor 1 (RTEF-1) is a key transcriptional regulator in endothelial function. In this study, we investigated a possible role for RTEF-1 in the regulation of microvascular relaxation and the underlying mechanism involved. Activation of fibroblast growth factor receptor 1 (FGFR1) by FGFs increases vasodilation, although transcriptional control of the molecular mechanisms underlying FGFR1 is still unclear. MATERIALS AND

methodsWe demonstrated that RTEF-1 stimulated FGFR1 expression at the transcriptional level, specifically an area including Sp1 elements, as evidenced by promoter assays. Additionally, RTEF-1 increased FGFR1 mRNA and protein expression in vitro and in VE-cadherin-promoted RTEF-1 (VE-Cad/RTEF-1) transgenic mice, whereas RTEF-1 siRNA blocked the upregulation of FGFR1 expression. Furthermore, increased endothelial-dependent microvessel relaxation was observed in the coronary arteries of VE-Cad/RTEF-1 mice, and increased proliferation was observed in RTEF-1-overexpressing cells, both of which correlated to increased FGF/FGFR1 signaling and endothelial nitric oxide synthase (eNOS) upregulation. Our results indicate that RTEF-1 acts as a transcriptional stimulator of FGFR1 and is involved in FGF pathways by increasing microvessel dilatation via eNOS.

conclusionsThese findings suggest that RTEF-1 plays an important role in FGFR1- stimulated vasodilatation. Understanding the effect of RTEF-1 in microvessel relaxation may provide beneficial knowledge in improving treatments in regards to ischemic vascular disorders.

Indexed as

VasodilationAnimalsCattleCell ProliferationCells, CulturedDNA-Binding ProteinsEndothelium, VascularHumansMicrovesselsMuscle ProteinsNitric Oxide Synthase Type IIIPromoter Regions, GeneticReceptor, Fibroblast Growth Factor, Type 1Signal TransductionTEA Domain Transcription FactorsTranscription FactorsDNA-Binding ProteinsFGFR1 protein, humanMuscle ProteinsNitric Oxide Synthase Type IIIReceptor, Fibroblast Growth Factor, Type 1TEAD4 protein, humanTEA Domain Transcription FactorsTranscription Factors

Identifiers

PMID22433836
PMCPMC3369257
OpenAlexW2076127113

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.